HOME >> BIOLOGY >> NEWS
Pitt trains budding engineers to 'think green'

Dwindling natural resources mean that engineers of the 21st century, more than ever before, must be conscious of environmental constraints. To help train the next generation of engineers to think green, the Mascaro Sustainability Initiative (MSI) in the University of Pittsburgh's School of Engineering has created a Sustainable Engineering Fellowship Program, which will begin in fall 2006.

The interdisciplinary program for Pitt engineering Ph.D. students will be supported by a three-year, $506,000 grant from the U.S. Department of Education's Graduate Assistance in Areas of National Need program.

"Engineers must understand that the world is a finite place with finite resources, and next generation products and processes must be designed within the framework of this complex system," said Eric Beckman, codirector of MSI and Bayer Professor of Chemical Engineering at Pitt.

"This grant will enable us to engage a diverse and talented group of students to translate the fundamental science of sustainability into real products and processes," added MSI codirector Gena Kovalcik.

Pitt engineering students already can travel to the University at Campinas in So Paulo, Brazil, to conduct research in green construction and sustainable water use technology under a University program funded by a $3.2 million Integrative Graduate Education and Research Traineeship grant from the National Science Foundation.

Engineering professors at the University also are collaborating on a project called "Research in Sustainable Community Development," which will support an international workshop to generate a research agenda in the areas of green construction and water that is attentive to cross-cultural and ethical issues.


'"/>

Contact: Karen Hoffmann
klh52@pitt.edu
412-624-4356
University of Pittsburgh
4-May-2006


Page: 1

Related biology news :

1. Strains of laboratory mice more varied than previously thought
2. Complexity constrains evolution of human brain genes
3. Newly identified strains of Chlamydia trachomatis could produce new diseases
4. New anthrax inhibitor could combat antibiotic-resistant strains
5. Human behavior changes the number of strains of infectious diseases
6. Fibril shape is the basis of prion strains and cross-species prion infection
7. Antibody that neutralizes most HIV strains described by scientists at The Scripps Research Institute
8. Study methods, strains of Pfiesteria are both critical in determining organisms toxicity
9. Bacterial spread all down to chance: Some strains just the lucky ones
10. Genome comparison of four campylobacter strains yields new genetic markers and clues to virulence
11. New tuberculosis antibiotic may shorten treatment time, fight drug-resistant strains

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pitt trains budding engineers think green

(Date:7/23/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software ... ended June 30, 2015.  Revenue for the ... 33% compared to $6.8 million in the same quarter last ... $0.3 million, or $0.01 per diluted share, which compared to ... period a year ago.  Lower revenue and ...
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), a ... it will report financial results for the fourth quarter ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce ... Lyon County Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center ... come from and how agriculture impacts their daily lives. This unique exhibit also features ...
(Date:7/30/2015)... Washington , July 30, 2015 ... Market, by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial ... Discovery & Development, Preclinical, Clinical Trial), by End Users ... Biosimulation Market is expected to reach USD 2,107.99 million ... a CAGR of 15.29%. Browse more ...
(Date:7/30/2015)... 2015 Ascendis Pharma A/S (Nasdaq: ... innovative TransCon technology to address significant unmet medical ... six-month Phase 2 study to evaluate the safety ... 53 treatment-naïve, pre-pubertal children with growth hormone deficiency, ... with the top-line results from our Phase 2 ...
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
Cached News: